China

News

Sanofi grabs Chinese rights to Arrowhead rare disease drug

Sanofi has paid $130 million upfront for Chinese rights to an Arrowhead Pharma drug for rare disease familial chylomicronaemia syndrome.

News

Bayer files HER2+ lung cancer drug in China

Bayer files its oral HER2+ lung cancer drug in China, as it extends a race to market with rival Boehringer Ingelheim.

News

AZ taps Chinese firm CSPC's AI acumen in $5.2bn+ alliance

AstraZeneca taps China's CSPC Pharma for new drug candidates a second time – and the latest AI-focused alliance is a big one.

News

Ascletis says oral acne drug shows "exceptional efficacy"

Phase 3 results for Ascletis' novel acne candidate have set up filings in China and bode well for a similar drug being developed by Sagimet in the US.

News

Report says US biotech needs $15bn support to fend off China

The US is close to falling behind China in biotech and the government should spend a minimum of $15bn over the next five years to support the sector.

News

Building site with thre emen in high viz jackets and protective headweare

AZ builds in China, as J&J ramps up its US investments

AstraZeneca will open its sixth R&D centre in China, while J&J announces four new manufacturing facilities in the US in a major reshoring drive.

Sanofi grabs Chinese rights to Arrowhead rare disease drug

Bayer files HER2+ lung cancer drug in China

AZ taps Chinese firm CSPC's AI acumen in $5.2bn+ alliance

Ascletis says oral acne drug shows "exceptional efficacy"

Report says US biotech needs $15bn support to fend off China

AZ builds in China, as J&J ramps up its US investments

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

China

Editor's Picks